Pages that link to "Q43585054"

The following pages link to Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors (Q43585054):

Displaying 17 items.

• Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors (Q33770040) (← links)
• Genotypic testing for human immunodeficiency virus type 1 drug resistance (Q33906239) (← links)
• A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes (Q34102058) (← links)
• Saquinavir: a review of its use in boosted regimens for treating HIV infection (Q35147073) (← links)
• Treatment of antiretroviral-drug-resistant HIV-1 infection (Q35610798) (← links)
• Genotype, phenotype, and virtual phenotype: who needs what and why? (Q35676512) (← links)
• Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro. (Q36047851) (← links)
• Nelfinavir: a review of its use in the management of HIV infection (Q36286228) (← links)
• Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India (Q36607906) (← links)
• Development of protease inhibitors and the fight with drug-resistant HIV-1 variants (Q37034610) (← links)
• GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro (Q37115695) (← links)
• Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir. (Q37235740) (← links)
• Prevalence and virologic consequences of HIV-1 genotype mutations detected in a cohort of 161 Italian patients receiving a nelfinavir-based highly active antiretroviral therapy (Q44471914) (← links)
• "All-in-One Assay", a direct phenotypic anti-human immunodeficiency virus type 1 drug resistance assay for three-drug combination therapies that takes into consideration in vivo drug concentrations (Q44487783) (← links)
• Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel (Q45722783) (← links)
• [Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002]. (Q53966961) (← links)
• Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study (Q56791530) (← links)